Trovagene Announces First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi attack on Saudi airport kills 12, over 300 wounded, authorities say
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Piper Jaffray Cuts Price Target on Trovagene (TROV) Following 1Q Miss
May 11, 2016 8:06 AM EDTPiper Jaffray maintained a Neutral rating on TrovaGene (NASDAQ: TROV), and cut the price target to $5.00 (from $8.00), following the company's 1Q earnings report. Trovagene reported revenue of $120K, well below the Street's ~$280K estimate. Adjusted EPS of ($0.36) was $0.07 below the Street estimate of ($0.29).
Analyst... More
Trovagene (TROV) Misses Q1 EPS by 7c
May 10, 2016 4:53 PM EDTTrovagene (NASDAQ: TROV) reported Q1 EPS of ($0.36), $0.07 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $120 thousand versus the consensus estimate of $260 thousand.
For earnings history and earnings-related data on Trovagene (TROV) click here.
... More


